These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8500874)

  • 21. Genetic exchange of the S2 and S3 subunits in pertussis toxin.
    Raze D; Veithen A; Sato H; Antoine R; Menozzi FD; Locht C
    Mol Microbiol; 2006 Jun; 60(5):1241-50. PubMed ID: 16689799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of subunits of pertussis toxin in Tn5-induced Bordetella mutants deficient in toxin biological activity.
    Marchitto KS; Munoz JJ; Keith JM
    Infect Immun; 1987 May; 55(5):1309-13. PubMed ID: 2883124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surface expression of a protective recombinant pertussis toxin S1 subunit fragment in Streptococcus gordonii.
    Lee SF; March RJ; Halperin SA; Faulkner G; Gao L
    Infect Immun; 1999 Mar; 67(3):1511-6. PubMed ID: 10024603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Construction and characterization of genetically inactivated pertussis toxin.
    Brown DR; Keith JM; Sato H; Sato Y
    Dev Biol Stand; 1991; 73():63-73. PubMed ID: 1778335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of a synthetic pertussis toxin operon in Escherichia coli.
    Pozza TD; Yan H; Walker MJ
    Vaccine; 1997 Jun; 15(9):968-75. PubMed ID: 9261943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibodies that define neutralizing epitopes of pertussis toxin: conformational dependence and epitope mapping.
    Lang AB; Ganss MT; Cryz SJ
    Infect Immun; 1989 Sep; 57(9):2660-5. PubMed ID: 2474500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific lung mucosal and systemic immune responses after oral immunization of mice with Salmonella typhimurium aroA, Salmonella typhi Ty21a, and invasive Escherichia coli expressing recombinant pertussis toxin S1 subunit.
    Walker MJ; Rohde M; Timmis KN; Guzmán CA
    Infect Immun; 1992 Oct; 60(10):4260-8. PubMed ID: 1398937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification and immunogenicity of a recombinant Bordetella pertussis S1S3FHA fusion protein expressed by Streptococcus gordonii.
    Lee SF; Halperin SA; Knight JB; Tait A
    Appl Environ Microbiol; 2002 Sep; 68(9):4253-8. PubMed ID: 12200273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural and functional analysis of the S1 subunit of pertussis toxin using synthetic peptides.
    Chong P; Sydor M; Wu E; Zobrist G; Boux H; Klein M
    Mol Immunol; 1991 Mar; 28(3):239-45. PubMed ID: 2017195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of linear B-cell determinants of pertussis toxin associated with the receptor recognition site of the S3 subunit.
    Schmidt MA; Raupach B; Szulczynski M; Marzillier J
    Infect Immun; 1991 Apr; 59(4):1402-8. PubMed ID: 1706321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contribution of the B oligomer to the protective activity of genetically attenuated pertussis toxin.
    Arciniega JL; Shahin RD; Burnette WN; Bartley TD; Whiteley DW; Mar VL; Burns DL
    Infect Immun; 1991 Oct; 59(10):3407-10. PubMed ID: 1894354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversal of the CD4(+)/CD8(+) T-cell ratio in lymph node cells upon in vitro mitogenic stimulation by highly purified, water-soluble S3-S4 dimer of pertussis toxin.
    Latif R; Kerlero de Rosbo N; Amarant T; Rappuoli R; Sappler G; Ben-Nun A
    Infect Immun; 2001 May; 69(5):3073-81. PubMed ID: 11292726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural relationship between the S1 and S4 subunits of pertussis toxin.
    Sato H; Sato Y
    FEMS Microbiol Lett; 1994 Jan; 115(1):63-9. PubMed ID: 7510256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune response to dimeric subunits of the pertussis toxin B oligomer.
    Hausman SZ; Burns DL; Sickler VC; Manclark CR
    Infect Immun; 1989 Jun; 57(6):1760-4. PubMed ID: 2722238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective immunogenicity of two synthetic peptides selected from the amino acid sequence of Bordetella pertussis toxin subunit S1.
    Askelöf P; Rodmalm K; Wrangsell G; Larsson U; Svenson SB; Cowell JL; Undén A; Bartfai T
    Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1347-51. PubMed ID: 2304902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fusion expression and immunogenicity of Bordetella pertussis PTS1-FHA protein: implications for the vaccine development.
    Jinyong Z; Xiaoli Z; Weijun Z; Ying G; Gang G; Xuhu M; Quanming Z
    Mol Biol Rep; 2011 Mar; 38(3):1957-63. PubMed ID: 20878241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA vaccine encoding pertussis toxin S1 subunit induces protection against Bordetella pertussis in mice.
    Kamachi K; Konda T; Arakawa Y
    Vaccine; 2003 Nov; 21(31):4609-15. PubMed ID: 14575775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pertussis holotoxoid formed in vitro with a genetically deactivated S1 subunit.
    Bartley TD; Whiteley DW; Mar VL; Burns DL; Burnette WN
    Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8353-7. PubMed ID: 2554311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Properties of the B oligomer of pertussis toxin.
    Nencioni L; Pizza MG; Volpini G; De Magistris MT; Giovannoni F; Rappuoli R
    Infect Immun; 1991 Dec; 59(12):4732-4. PubMed ID: 1937835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cloning and sequencing of the pertussis toxin genes: operon structure and gene duplication.
    Nicosia A; Perugini M; Franzini C; Casagli MC; Borri MG; Antoni G; Almoni M; Neri P; Ratti G; Rappuoli R
    Proc Natl Acad Sci U S A; 1986 Jul; 83(13):4631-5. PubMed ID: 2873570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.